Implications of oxidative stress and hepatic cytokine (TNF-α and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity

被引:103
作者
Das, S [1 ]
Santra, A [1 ]
Lahiri, S [1 ]
Mazumder, DNG [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Kolkata, W Bengal, India
关键词
arsenic; hepatotoxicity; proinflammatory cytokines; oxystress;
D O I
10.1016/j.taap.2004.08.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Noncirrhotic portal fibrosis has been reported to occur in humans due to prolonged intake of arsenic contaminated water. Further, oxystress and hepatic fibrosis have been demonstrated by us in chronic arsenic induced hepatic damage in murine model. Cytokines like tumor necrosis factor a (TNF-alpha) and interleukin 6 (IL-6) are suspected to play a role in hepatic collagenesis. The present study has been carried out to find out whether increased oxystress and cytokine response are associated with increased accumulation of collagen in the liver due to prolonged arsenic exposure and these follow a dose-response relationship. Methods: Male BALB/c mice were given orally 200 mu l of water containing arsenic in a dose of 50, 100, and 150 mu g/mouse/day for 6 days a week (experimental group) or arsenic-free water (< 0.01 mu g/l, control group) for 3, 6, 9 and 12 months. Hepatic glutathione (GSH), protein sulfhydryl (PSH), glutathione peroxidase (GPx), Catalase, lipid peroxidation (LPx), protein carbonyl (PC), interleukin (IL-6), tumor necrosis factor (TNF-alpha), arsenic and collagen content in the liver were estimated from sacrificed animals. Results: Significant increase of lipid peroxidation and protein oxidation in the liver associated with depletion of hepatic thiols (GSH, PSH), and antioxidant enzymes (GPx, Catalase) occurred in mice due to prolonged arsenic exposure in a dose-dependent manner. Significant elevation of hepatic collagen occurred at 9 and 12 months in all the groups associated with significant elevation of TNF-alpha and IL-6. However, arsenic level in the liver increased progressively from 3 months onwards. There was a positive correlation between the hepatic arsenic level and collagen content (r = 0.8007), LPx (r = 0.779) and IL-6 (r = 0.7801). Further, there was a significant negative correlation between GSH and TNF-alpha (r = -0.5336)) and LPx (r = -0.644). Conclusion: Increasing dose and duration of arsenic exposure in mice cause progressive increase of oxystress and elevation of cytokines associated with increasing level of collagen in the liver. (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 69 条
[1]   Arsenic: Health effects, mechanisms of actions, and research issues [J].
Abernathy, CO ;
Liu, YP ;
Longfellow, D ;
Aposhian, HV ;
Beck, B ;
Fowler, B ;
Goyer, R ;
Menzer, R ;
Rossman, T ;
Thompson, C ;
Waalkes, M .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 (07) :593-597
[2]   Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity [J].
Aposhian, HV .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :397-419
[3]   ONLINE PHOTOOXIDATION FOR THE DETERMINATION OF ORGANOARSENIC COMPOUNDS BY ATOMIC-ABSORPTION SPECTROMETRY WITH CONTINUOUS ARSINE GENERATION [J].
ATALLAH, RH ;
KALMAN, DA .
TALANTA, 1991, 38 (02) :167-173
[4]   TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND TRANSFORMING GROWTH-FACTOR BETA-1 (TGF-BETA-1) STIMULATE FIBRONECTIN SYNTHESIS AND THE TRANSDIFFERENTIATION OF FAT-STORING CELLS IN THE RAT-LIVER INTO MYOFIBROBLASTS [J].
BACHEM, MG ;
SELL, KM ;
MELCHIOR, R ;
KROPF, J ;
ELLER, T ;
GRESSNER, AM .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1993, 63 (02) :123-130
[5]   THE PATHOLOGY OF HEPATIC IRON OVERLOAD - A FREE-RADICAL MEDIATED PROCESS [J].
BACON, BR ;
BRITTON, RS .
HEPATOLOGY, 1990, 11 (01) :127-137
[6]   HEPATIC LIPID-PEROXIDATION INVIVO IN RATS WITH CHRONIC IRON OVERLOAD [J].
BACON, BR ;
TAVILL, AS ;
BRITTENHAM, GM ;
PARK, CH ;
RECKNAGEL, RO .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (03) :429-439
[7]   NADPH-DRIVEN LIPID-PEROXIDATION IN RAT-LIVER NUCLEI AND NUCLEAR-MEMBRANES [J].
BAIRD, MB ;
BIRNBAUM, LS ;
SFEIR, GT .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1980, 200 (01) :108-115
[9]  
Ballatori N, 1994, Adv Pharmacol, V27, P271, DOI 10.1016/S1054-3589(08)61036-4
[10]  
BEERS RF, 1952, J BIOL CHEM, V195, P133